Published in Health and Medicine Week, December 4th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Provectus Pharmaceuticals.
Report 1: Provectus Pharmaceuticals, Inc., (PVCT) announced that Peter Hersey, MD, presented results at the third annual International Melanoma Research Congress that outlined how the company's leading anticancer agent, PV-10, completely ablated a cluster of metastatic melanoma tumors afflicting a clinical trial participant.
Hersey, an oncologist and leading international authority on melanoma, noted treatment of one of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.